US PHARMA FIRM MODERNA SAYS ITS COVID-19 VACCINE IS 94.5% EFFECTIVE

© Provided by dw.com US pharmaceutical firm Moderna announced on Monday that early analysis of its COVID-19 vaccine suggested that it was as much as 94.5% effective. "This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease," said Stephane Bancel, Moderna's CEO. Th...